Earnings Call · Q2 FY2021·2021-08-09

Q2 21EPS -4.26%·Rev n/aQ1 21EPS +6.56%·Rev n/aQ4 20EPS -28.38%·Rev n/aQ3 20EPS +14.63%·Rev n/a⚠ consensus missing

Atara Biotherapeutics, Inc. ATRA

Eric Hyllengren — Chief Financial Officer or Senior Executive

Pascal Touchon — Chief Executive Officer or President

Jakob Dupont — Chief Medical Officer or Senior Executive in Clinical Development

+2.0%1d on move date+1.9% vs SPY3d+0.6%5d−0.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATRA calls or request research access.

More ATRA calls Browse calls Request research access